Serialization status in ‘Year Zero’

Although the Drug Supply Chain Security Act (DSCSA) was passed in 2013 and has implementation milestones that have already been achieved, 2017 can be considered “Year Zero” for the law’s fundamental requirement: to put a unique identification code on each […]

Read More

US pharma product recalls jumped at the end of 2016

There are two types of reverse logistics relevant to the pharma industry: product returns—usually a business decision based on overstock at pharmacies and the like; and recalls—usually performed with the recommendation if not requirement of FDA for faulty products. For […]

Read More

HDA Specialty Distribution 2016 report

As the fortunes of the Big Three drug wholesalers get whipsawed by changing dynamics in conventional drug distribution, their specialty subsidiaries, along with those of other participants in specialty distribution, are the glowing bright spot in the field. As more […]

Read More